Interface (TILE) earnings call transcripts

Management framed the quarter as broad-based execution, with durable productivity gains supporting a raised outlook despite tariff and input-cost timing.

Management framed the quarter as broad-based execution validating One Interface, with healthy demand and additional efficiency gains still available.

Management framed 2026 as an execution year, with automation, cross-selling and noravant extending growth while tariffs test margin expansion.

Management portrayed stronger-than-expected healthcare demand and earlier productivity gains, while remaining deliberately cautious about further margin expansion and 2026 investment.

Management framed the quarter as broad-based, self-help-led momentum, with Americas growth and automation offsetting macro uncertainty.

Management framed Q1 as a solid launchpad, with Americas strength, diversification and April order acceleration offsetting EAAA softness and macro uncertainty.

Management framed the quarter as early proof that One Interface is accelerating share gains, cross-selling and structural margin recovery.

Management framed Q2 as early validation of One Interface, with execution and productivity offsetting uneven end markets and supporting higher full-year margin expectations.

Management framed the quarter as early validation of One Interface, with stronger orders and mix-led margin gains despite a difficult macro backdrop.

Management framed 2024 as cautious growth, supported by share gains, commercial execution, and planned productivity investment.